Tsveta Milanova, Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 2,872 shares at $27.02 ($78K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Scheduled sale ($78k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $186K | — | Filing → |
| AGIO | SELL | 2025-03-04 | $119K | — | Filing → |